Results 191 to 200 of about 41,456 (235)
Pharmacokinetics, safety and preliminary efficacy study of montelukast in critically ill infants with developing bronchopulmonary dysplasia (PRISM). [PDF]
Contemp Clin Trials CommunLang JE +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pediatric Anesthesia, 2021
AbstractBronchopulmonary dysplasia is the most frequent adverse outcome of prematurity. Before implementation of antenatal steroids and surfactant therapy, bronchopulmonary dysplasia was mostly characterized by fibrotic, scarred, and hyper‐inflated lungs due to pulmonary injury following mechanical ventilation and oxygen toxicity.
Alexander R. Schmidt +1 more
+5 more sources
AbstractBronchopulmonary dysplasia is the most frequent adverse outcome of prematurity. Before implementation of antenatal steroids and surfactant therapy, bronchopulmonary dysplasia was mostly characterized by fibrotic, scarred, and hyper‐inflated lungs due to pulmonary injury following mechanical ventilation and oxygen toxicity.
Alexander R. Schmidt +1 more
+5 more sources
The Lancet, 2006
Bronchopulmonary dysplasia is a chronic lung disease that affects premature babies and contributes to their morbidity and mortality. Improved survival of very immature infants has led to increased numbers of infants with this disorder. This increase puts a heavy burden on health resources since these infants need frequent re-admission to hospital in ...
Kinsella, J P, Greenough, A, Abman, S H
+8 more sources
Bronchopulmonary dysplasia is a chronic lung disease that affects premature babies and contributes to their morbidity and mortality. Improved survival of very immature infants has led to increased numbers of infants with this disorder. This increase puts a heavy burden on health resources since these infants need frequent re-admission to hospital in ...
Kinsella, J P, Greenough, A, Abman, S H
+8 more sources
Pediatric Annals, 1990
Bronchopulmonary dysplasia (BPD) is a serious lung disease which is increasingly recognised in prematurely born infants in neonatal intensive care units. Little is known about the cause of the disease, the treatment is mainly empirical. Although oxygen is well known to be one of the causal agents for BPD, it is, at the same time, part of its treatment.
Richard B. Parad, Mary Ellen B. Wohl
+6 more sources
Bronchopulmonary dysplasia (BPD) is a serious lung disease which is increasingly recognised in prematurely born infants in neonatal intensive care units. Little is known about the cause of the disease, the treatment is mainly empirical. Although oxygen is well known to be one of the causal agents for BPD, it is, at the same time, part of its treatment.
Richard B. Parad, Mary Ellen B. Wohl
+6 more sources
Journal of Thoracic Imaging, 1986
Neonatal pulmonary diseases may require mechanical ventilation and supplemental oxygen therapy. These supportive measures can damage the immature lung or distort the normal maturation processes of the developing lung. The formation of hyaline membranes occurs acutely, often complicated by left-to-right cardiac shunts.
J L, Williams, W A, Cumming
openaire +4 more sources
Neonatal pulmonary diseases may require mechanical ventilation and supplemental oxygen therapy. These supportive measures can damage the immature lung or distort the normal maturation processes of the developing lung. The formation of hyaline membranes occurs acutely, often complicated by left-to-right cardiac shunts.
J L, Williams, W A, Cumming
openaire +4 more sources
Pediatrics, 1982
In their detailed study of the long-term survivors of bronchopulmonary dysplasia (BPD) Smyth and colleagues1 contrast their findings of a high incidence of abnormal pulmonary function in early childhood with the commonly held view that pulmonary function becomes normal in most children surviving BPD.2 However, they do not give us detailed parameters of
openaire +2 more sources
In their detailed study of the long-term survivors of bronchopulmonary dysplasia (BPD) Smyth and colleagues1 contrast their findings of a high incidence of abnormal pulmonary function in early childhood with the commonly held view that pulmonary function becomes normal in most children surviving BPD.2 However, they do not give us detailed parameters of
openaire +2 more sources
Understanding Bronchopulmonary Dysplasia
Archives of Pediatrics & Adolescent Medicine, 1986The term bronchopulmonary dysplasia (BPD) was initially introduced to describe chronic pulmonary changes that occurred in certain premature infants following respiratory distress syndrome (RDS). 1 Subsequently, BPD has been recognized as a sequela of other forms of severe lung disease in newborn infants.
openaire +2 more sources
Bronchopulmonary dysplasia-pathology
The Journal of Pediatrics, 1979The term bronchopulmonary dysplasia has much to commend it. It does not declare the etiology of this disease, which seems to be an advantage. Another advantage is that it presents the idea of disturbance of growth as well as scarring. The premature lung responds at birth somewhat differently from the mature lung, not just in respect to surfactant but ...
openaire +2 more sources
Respiratory care, 2009
Bronchopulmonary dysplasia (BPD) is the most common chronic respiratory disease that results from complications related to the lung injury during the treatment of respiratory distress syndrome, or develops in older infants when abnormal lung growth occurs.
Yuranga Weerakkody +2 more
openaire +3 more sources
Bronchopulmonary dysplasia (BPD) is the most common chronic respiratory disease that results from complications related to the lung injury during the treatment of respiratory distress syndrome, or develops in older infants when abnormal lung growth occurs.
Yuranga Weerakkody +2 more
openaire +3 more sources
Archives francaises de pediatrie, 1991
Bronchopulmonary dysplasia (BPD) is one of the most serious complications of neonatal intensive care. This chronic lung disease usually follows early pulmonary injuries. Surfactant defect, oxygen toxicity and barotrauma are three major factors leading to diffuse alveolar and bronchiolar damage, first step of BPD.
V, Zupan, D, Leyronnas, M, Dehan
openaire +3 more sources
Bronchopulmonary dysplasia (BPD) is one of the most serious complications of neonatal intensive care. This chronic lung disease usually follows early pulmonary injuries. Surfactant defect, oxygen toxicity and barotrauma are three major factors leading to diffuse alveolar and bronchiolar damage, first step of BPD.
V, Zupan, D, Leyronnas, M, Dehan
openaire +3 more sources